SWOT
Uploaded by
ScribdTranslationsSWOT
Uploaded by
ScribdTranslationsPfizer was founded by cousins Charles Pfizer and Charles Erhart in 1849.
The company had a
early success with an antiparasitic called Santonin, but experienced growth
significant after its shift to citric acid production in the 1880s. It focused on
the production of citric acid throughout most of the first half of the 20th century, despite
some difficulties caused by the First and Second World Wars.
Once penicillin became more readily available, Pfizer began to develop and
market new antibiotic products, ultimately changing the approach of the
from a fine chemicals manufacturer company to an absolute pharmaceutical company.
Pfizer continued to develop its product portfolio and expanded its interests internationally,
establishing offices in Europe, North America, and Latin America in the 1950s.
Pfizer has continued to expand and grow, and today it is not just one of the largest pharmaceutical groups...
one of the largest companies in any sector, with a network
international offices and research facilities, and nearly 100,000 employees.
The company is ranked 55th on the Fortune 500 list. Pfizer's shares are traded on the
New York Stock Exchange. It has a current market capitalization of $212.18 billion.
The SWOT analysis helps us observe the internal and external factors, as well as the
positive and negative sources faced by the company Pfizer.
Among those factors, it provides us with a clear indicator to make decisions on strategies for a better
performance from the present to the future within the organization.
These measures are by element within this company in the Health Sector:
STRENGTHS
Global Presence.
Pfizer is the number one pharmaceutical company in the world, which has a presence in 180 countries.
currently has established a strong positioning in the Health Sector market.
Variety in Products.
Pfizer is characterized by having a wide range of products in all kinds such as:
Cardiovascular, Antimicrobials, Hemostatic, Hematology / Oncology, Antivirals,
Anticonvulsivos, Agente somnífero, Analgésicos neurológicos, Antidepresivos, Hormonales,
Gastrointestinal, Cancer Treatments, Ophthalmological, Diabetes Therapy, among others
more. These support having a large supply for the growing demand in the Health Sector.
Number 1 in pharmaceutical sales in the world.
The largest pharmaceutical company in the world recorded profits of 53.7 billion in 2018.
in dollars. It surpassed its rival Roche with sales of 45.6 billion dollars. This is due to a
great patent protection mainly in the oncology section that guarantees important
utilities to Pfizer.
Investments in research and development areas of new products.
Pfizer is a company that spares no resources for constant innovation.
products and services to continue positioning itself as the number one pharmaceutical company in the world.
A large part of this development is what owes its market positioning and depth to the
future permanence for many more years due to the patent protection it has and continues
developing.
Globally recognized brand.
The company Pfizer is recognized as number one and its brand does not go unnoticed.
majority of the world's population. It gives great confidence to consumers that they are
buying quality products.
Satisfaction with their customers.
Quality at Pfizer is paramount, offering patented and top-tier products is what has
characterized by having market confidence and continuing to be strong against pharmaceuticals of
world.
Highly qualified team.
Their human factor is essential, as they are highly committed to quality and service.
Client, better conditions for the human factor directly influence providing better service.
OPPORTUNITIES
Contribute to Humanity.
Pfizer is a company that has contributed to great advances in medicine since its founding.
Its great team and experience have solidified the market and the forward-looking vision is clear with
great invasions and new future patents for the service of the world population.
Better quality of life for patients.
Thanks to the fervent dedication of the human factor, extensive experience, and high training in
constantly acquiring knowledge has resulted in high-quality products that have
helped to improve the illnesses of their patients and others, to improve their living conditions.
Continuous improvement of operations.
The resources that the company has (human, financial, technical, technological) have led to a
primary positioning of the company. But it does not rule out adaptation and innovation in the market
changing. It adapts according to the situations and new trends that the world demands.
to be at the forefront.
Social Support.
It is a company that has been dedicated to campaigns for the benefit of the health sector.
free medications, training for communities on first aid and what to do in
certain cases with different patients. Continue innovating and supporting more and more programs in
benefit to humanity.
Technology.
We cannot deny that we are in the era of technology, and it is thanks to it that has given
a giant leap to develop new ways to heal patients.
Mutation and new diseases.
The world is very changing and little by little, viruses, bacteria, etc., are constantly changing.
and they become more receptive to medications and even new ones are developed.
the pharmaceutical industry must venture into a new horizon in order to develop new
products that can meet the growing demand of patients.
WEAKNESSES
Loss of Patents.
Pfizer has had exclusivity on some drugs due to patent protection. However,
after the agreed time has passed, these formulas become open for use and can be utilized by
any other pharmaceutical company that can launch the product at a better price usually for
obtain profits.
Generics
This product range encourages patients to obtain more accessible medications.
price. Causing significant losses by not having the income from their drugs due to having a substitute.
of license and at an even higher price.
Failed investments in drugs.
Pfizer bets large amounts of resources on permanent innovation, which has characterized it.
a wide range of diverse products. However, not all the investments made are successful,
and it is when the company, having a failed drug, loses large sums of billions
dollars which are now going directly to a lost fund.
High costs.
The pharmaceutical industry spends significant amounts of money to process and innovate.
consume, distribute, marketing and advertising, salaries, among others which are going in
increase due to resource scarcity and inflation according to the country.
THREATS
Public Health Issues of Drugs.
It has been reported that not all the medicines launched by Pfizer are...
beneficial to patients. Like any medication, there are side effects which in
sometimes are not so alarming, but at times they reach a higher percentage of the population than
expected. Products like the drug Bextra as an anti-inflammatory and Advil for children as a pain reliever
fever has forced the State to order the withdrawal of drugs from the market and remedy the aftermath
from them to the affected patients.
High competition in the pharmaceuticals.
Pfizer positions itself as the number one pharmaceutical company in the world. However, its biggest
competitors such as Roche, Johnson & Johnson, Sanofi, Merck & Co., Novartis, Genoma Lab,
They approach the giant and a bad decision could cause their stay at the top to not be
forever.
Legal Framework of Law.
The legal regulations in the rule of law directly impact the conditions of
market and consequently in the pharmaceutical industry. At times it can be beneficial.
and in others, it can mean a reengineering in the industry that involves billions for
to be able to adapt to the new legal regulations of the State.
International Treaties.
There are blockages that usually lead to a change in all economic sectors and the sector
health is no exception, adapting to the new political and economic rules is paramount if
they want to survive in the market.
Natural Disasters.
An event of this level is not expected, it just happens, and it is when it can cause a
social destabilization that is sometimes uncontrollable and exceeds medical resources
existing ones, causes a collapse and there may be losses in the industry if looting occurs
drugs or if there were any impacts on the company's assets, the same applies.
principle.
